Publication dates

Cancer Immunotherapy Industry, July 2014 Market Research & Statistics

You might be interested in: vaccine

1-10 of about 200 reports for Cancer Immunotherapy

Pathology Description in India - Forecast

  • Media Coverage of Canmabtm Launch Announcement, Jan 18, 2014
  • January 2014
    50 pages
  • Breast Cancer  

    Cancer  

    Drug  

  • India  

    World  

View report >

Pathology Industry - Investor Report, January 2014

  • Innovative Science Affordable Medicine
  • January 2014
    48 pages
  • Biosimilars  

  • India  

    World  

View report >

Pathology Description in the US - Forecast

  • Umbrella Research
  • January 2012
    33 pages
  • Cancer  

    Crohn's Disease  

  • United States  

View report >

Pathology Description in the US - Forecast

  • Umbrella Research
  • January 2012
    33 pages
  • Cancer  

    Crohn's Disease  

  • United States  

View report >

Pathology Description in the US

  • January 2012
    32 pages
  • Cancer  

  • United States  

    North America  

View report >

Bms - Annual Report, 2012

  • 2012 Annual Report
  • January 2012
    104 pages
  • United States  

View report >

Takara Holdings Incorporated - Annual Report, 2013

  • Excellence, Future of Innovation
  • January 2013
    68 pages
  • Japan  

View report >

Medigene - Annual Report, 2013

  • Tr Ansformation
  • January 2013
    145 pages
  • Germany  

View report >

Pathology Description in Europe

  • Background Paper 6.5 Cancer and Cancer Therapeutics
  • April 2013
    62 pages
  • Cancer  

  • Europe  

    United States  

    World  

View report >

Medinet - Annual Report, 2013

  • Http://www.edgar-online.com
  • January 2013
    171 pages
  • Equity Market  

    Preferred Stock  

    Common Stock  

  • United States  

View report >
32 reports for Cancer Immunotherapy

Purchase Reports From Reputable Market Research Publishers
(From $ 250 - $ 6 813)

Immunotherapy in Oncology Drug Pipeline Update 2014

Immunotherapy in Oncology Drug Pipeline Update 2014

  • $ 3 675
  • Industry report
  • July 2014
  • by Bioseeker

Cancer immunotherapy offers an attractive therapeutic addition, delivering treatment of high specificity, low toxicity and prolonged activity. In this Drug Pipeline Update BioSeeker brings together the ...



ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.